Macrocephaly mesodermal hamartoma spectrum
Macrocephaly Mesodermal Hamartoma Spectrum (MMHS) is a rare and complex condition that involves a spectrum of developmental anomalies primarily affecting the mesodermal tissue. This condition is characterized by the presence of macrocephaly, which is an abnormally large head circumference, and mesodermal hamartomas, which are benign, tumor-like growths made up of mesodermal tissue. The spectrum of this disorder can vary significantly from mild to severe, impacting various body systems.
Etiology[edit | edit source]
The exact cause of MMHS is not well understood, but it is believed to involve genetic mutations that affect the development of mesodermal tissues during fetal development. These mutations may be sporadic or inherited, but the specific genetic patterns and risk factors associated with MMHS are still under investigation.
Clinical Features[edit | edit source]
Patients with MMHS present a range of clinical features that can vary significantly in severity. The hallmark features include:
- Macrocephaly: An increased head circumference that is significantly larger than the norm for the patient's age and sex.
- Mesodermal Hamartomas: These are non-cancerous growths that can occur in various parts of the body, including the skin, heart, and kidneys. They are composed of an abnormal mixture of tissues that originate from the mesoderm layer of the embryo.
- Additional anomalies may include abnormalities of the skin, skeletal system, cardiovascular system, and other organs.
Diagnosis[edit | edit source]
Diagnosis of MMHS is based on clinical evaluation, detailed medical history, and a variety of diagnostic tests. These may include:
- Imaging studies such as MRI or CT scans to assess the extent of hamartomas and other structural abnormalities.
- Genetic testing to identify any known mutations associated with the condition.
- Biopsy of hamartomatous lesions to confirm their benign nature and mesodermal origin.
Treatment[edit | edit source]
There is no cure for MMHS, and treatment is symptomatic and supportive. Management strategies may include:
- Surgical removal of problematic hamartomas, especially if they are causing functional impairments or cosmetic concerns.
- Regular monitoring of growth and development, including head circumference and cognitive development.
- Multidisciplinary care involving specialists in genetics, neurology, dermatology, and other relevant fields to address the various aspects of the condition.
Prognosis[edit | edit source]
The prognosis for individuals with MMHS varies depending on the severity of the condition and the presence of associated anomalies. While some individuals may have mild symptoms and lead relatively normal lives, others may experience significant developmental delays, neurological issues, and other complications.
See Also[edit | edit source]
Macrocephaly mesodermal hamartoma spectrum Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD